An experimental COVID drug was so successful that they’re shutting down trials early

Published

3 years ago

12 April 2022

Terry Power

Experimental COVID drug sabizabulin cuts mortality rate in half for severe cases | Fortune

You need to enable JavaScript to view this site.

Related Topics:COVID drug early experimental shutting successful Theyre trials